Focus: Orca Bio is a cell therapy company focused on oncology and gene therapy, headquartered in Menlo Park, CA, developing advanced manufacturing and cell-based treatments for hematologic malignancies.
Profile data last refreshed 8h ago · AI intelligence enriched 1w ago
Stable — net +4 jobs in 30d
16 added, 12 removed. Backfill posture.
Best fit for manufacturing, QA, or supply-chain specialists seeking early-stage impact in cell therapy; higher risk tolerance required for preclinical/commercial roles.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Orca Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Orca Bio's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company